Status:
COMPLETED
Collagen Treatment in Facial Nerve Palsy
Lead Sponsor:
Uniter Onlus
Collaborating Sponsors:
University of Rome Tor Vergata
Conditions:
Facial Nerve Palsy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To test the effectiveness of a collagen-based treatment for patients complaining of long standing facial nerve axonotmesis, who are following a proprioceptive neuromuscular facilitation protocol (Kaba...
Detailed Description
Objective: To test the effectiveness of a collagen-based treatment for patients complaining of long standing facial nerve axonotmesis, who are following a proprioceptive neuromuscular facilitation pro...
Eligibility Criteria
Inclusion
- patients with a medical diagnosis of long-term unilateral peripheral axonotmesis of the facial nerve
Exclusion
- patients with facial palsy caused by central nerve disease;
- patients with a history of recurrent facial palsy;
- patients with a facial skin disease hampering the possibility of injecting the drug; - patients with difficulty in moving their face due to previous plastic surgery or facial surgery;
- patients with systemic diseases that can affect facial electromyography;
- patients deemed inappropriate by the researchers.
- patients with a history of hypersensitivity to any collagen solution constituent or showing pregnancy, lactation, neuromuscular junction disorders (myastenia gravis), peripheral motor neuropathies, or active infections will be also excluded.
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04353908
Start Date
July 1 2016
End Date
March 1 2020
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNITER ONLUS for balance and rehabilitation research
Guidonia, Rome, Italy, 00012